Abstract 277: Multiplex Epstein-Barr virus (EBV) serology in EBV-positive and -negative gastric cancer

@article{Camargo2014Abstract2M,
  title={Abstract 277: Multiplex Epstein-Barr virus (EBV) serology in EBV-positive and -negative gastric cancer},
  author={M. C. Camargo and A. Michel and K. Kim and K. Matsuo and L. Liao and J. Torres and J. Zabaleta and M. Gulley and Y. Yatabe and I. Alvarado-Cabrero and J. Lissowska and S. Kim and M. Pawlita and C. Rabkin},
  journal={Cancer Research},
  year={2014},
  volume={74},
  pages={277-277}
}
BACKGROUND: The leading cause of gastric cancer is chronic Helicobacter pylori infection. However, about 10% of these tumors also contain monoclonal Epstein-Barr virus (EBV), associated with clinicopathologic differences from EBV-negative tumors. While the vast majority of the world9s population is latently infected with EBV, viral reactivation is postulated to predispose to development of EBV-related tumors. To evaluate the association of EBV reactivation with EBV-positive gastric cancer, we… Expand